[GENP] QoQ Annualized Quarter Result on 30-Sep-2016 [#3]

Stock
[GENP] GENTING PLANTATIONS BERHAD
Announcement Date
23-Nov-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Sep-2016 [#3]
Profit Trend
QoQ- 81.2%
YoY- 14.28%
Quarter Report
Latest QR
Upcoming QR
GENP's Result
GENP's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 1,692,938 1,600,896 1,480,079 1,288,886 1,139,990 1,043,488 1,374,931 14.89%
PBT 421,682 429,432 448,771 253,612 134,118 153,968 247,429 42.72%
Tax -114,528 -118,292 -121,280 -72,600 -38,962 -41,764 -70,834 37.79%
NP 307,154 311,140 327,491 181,012 95,156 112,204 176,595 44.67%
-
NP to SH 287,016 290,956 338,213 198,620 109,614 107,952 189,749 31.80%
-
Tax Rate 27.16% 27.55% 27.02% 28.63% 29.05% 27.13% 28.63% -
Total Cost 1,385,784 1,289,756 1,152,588 1,107,874 1,044,834 931,284 1,198,336 10.18%
-
Net Worth 4,295,640 3,987,002 4,256,038 3,940,908 3,933,816 4,189,416 4,176,182 1.89%
Dividend
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Div 87,992 - 165,819 21,018 31,470 - 42,614 62.22%
Div Payout % 30.66% - 49.03% 10.58% 28.71% - 22.46% -
Equity
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Net Worth 4,295,640 3,987,002 4,256,038 3,940,908 3,933,816 4,189,416 4,176,182 1.89%
NOSH 799,933 797,400 789,617 788,181 786,763 784,534 774,801 2.15%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 18.14% 19.44% 22.13% 14.04% 8.35% 10.75% 12.84% -
ROE 6.68% 7.30% 7.95% 5.04% 2.79% 2.58% 4.54% -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 211.63 200.76 187.44 163.53 144.90 133.01 177.46 12.46%
EPS 35.88 36.52 42.84 25.20 13.94 13.76 24.49 29.02%
DPS 11.00 0.00 21.00 2.67 4.00 0.00 5.50 58.80%
NAPS 5.37 5.00 5.39 5.00 5.00 5.34 5.39 -0.24%
Adjusted Per Share Value based on latest NOSH - 782,850
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 188.76 178.50 165.03 143.71 127.11 116.35 153.30 14.89%
EPS 32.00 32.44 37.71 22.15 12.22 12.04 21.16 31.78%
DPS 9.81 0.00 18.49 2.34 3.51 0.00 4.75 62.24%
NAPS 4.7895 4.4454 4.7454 4.394 4.3861 4.6711 4.6563 1.89%
Price Multiplier on Financial Quarter End Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 -
Price 11.04 11.68 10.80 11.00 10.62 11.20 10.60 -
P/RPS 5.22 5.82 5.76 6.73 7.33 8.42 5.97 -8.56%
P/EPS 30.77 32.01 25.21 43.65 76.23 81.40 43.28 -20.35%
EY 3.25 3.12 3.97 2.29 1.31 1.23 2.31 25.58%
DY 1.00 0.00 1.94 0.24 0.38 0.00 0.52 54.70%
P/NAPS 2.06 2.34 2.00 2.20 2.12 2.10 1.97 3.02%
Price Multiplier on Announcement Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 23/08/17 29/05/17 22/02/17 23/11/16 25/08/16 23/05/16 22/02/16 -
Price 10.58 11.60 11.08 10.52 10.64 10.64 11.00 -
P/RPS 5.00 5.78 5.91 6.43 7.34 8.00 6.20 -13.37%
P/EPS 29.49 31.79 25.87 41.75 76.37 77.33 44.92 -24.48%
EY 3.39 3.15 3.87 2.40 1.31 1.29 2.23 32.24%
DY 1.04 0.00 1.90 0.25 0.38 0.00 0.50 63.01%
P/NAPS 1.97 2.32 2.06 2.10 2.13 1.99 2.04 -2.30%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment